Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
1.
J Virol ; 69(11): 7187-95, 1995 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-7474140

RESUMEN

Previous work demonstrated that a herpes simplex virus type 1 (HSV-1) immediate-early function up-regulates beta interferon but not chloramphenicol acetyltransferase reporter genes driven by the strong simian virus 40 (SV40) or cytomegalovirus promoter-enhancer regions in both transient assays and stable cell lines. The different 3' mRNA stabilization and RNA-processing signals from these two reporter genes appeared to be primarily responsible for this phenomenon. We now report that the HSV-1 ICP27 itself is sufficient to stimulate both steady-state accumulation and increased half-life of beta interferon reporter gene mRNA. Furthermore, the ability to respond directly to cotransfected ICP27 can be transferred to chloramphenicol acetyltransferase reporter genes by replacement of their SV40-derived splicing and poly(A) signals with the 3' AU-rich and poly(A) RNA-processing signals from the normally highly labile beta interferon and c-myc mRNA species. ICP27 expressed in bacteria bound specifically to in vitro-generated RNA from both the beta interferon and c-myc intronless AU-rich 3' RNA-processing regions, but not to the SV40-derived early-region splice signal and poly(A) sequences. By site-specific mutagenesis, we also show that individual ICP27 C-terminal amino acid residues that are positionally conserved in ICP27 homologs in other herpesviruses (D-357, E-358, H-479, C-400, C-483, and C-488) are critical for trans-regulatory activity. Importantly, several of these positions match mutations that are known to be essential for the role of ICP27 in the early-to-late switch during the virus lytic cycle. Therefore, our findings support the notion that HSV ICP27 modulates gene expression posttranscriptionally in part by targeting RNA.


Asunto(s)
Expresión Génica , Proteínas Inmediatas-Precoces , Interferón beta/biosíntesis , ARN Mensajero/metabolismo , Simplexvirus/genética , Simplexvirus/metabolismo , Transactivadores/metabolismo , Proteínas Virales/metabolismo , Secuencia de Aminoácidos , Línea Celular , Cloranfenicol O-Acetiltransferasa/biosíntesis , Secuencia Conservada , Citomegalovirus/genética , Elementos de Facilitación Genéticos , Glutatión Transferasa/biosíntesis , Humanos , Datos de Secuencia Molecular , Regiones Promotoras Genéticas , Unión Proteica , Proteínas Recombinantes de Fusión/biosíntesis , Proteínas Recombinantes de Fusión/aislamiento & purificación , Homología de Secuencia de Aminoácido , Virus 40 de los Simios/genética , Especificidad de la Especie , Transactivadores/biosíntesis , Transcripción Genética , Transfección , Proteínas Virales/biosíntesis , Proteínas Virales/química
2.
Br J Obstet Gynaecol ; 102 Suppl 12: 17-21, 1995 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-7577850

RESUMEN

In an open-label, multicentre, randomized, parallel group study, 164 women with endometriosis were assigned to treatment. Out of these women, 81 received danazol (600 mg daily for 8 weeks, then 400 mg for 16 weeks) and 83 were given gestrinone (2.5 mg twice a week for 24 weeks). Five weeks before the start of treatment clinical evaluation and diagnostic laparoscopy were performed during the screening visit. Drug assignment and laboratory data assessment were carried out within 3 days of the estimated onset of the menstrual cycle at baseline visit. The response to treatment was assessed during visits at weeks 2, 4, 8, 12, 16, 20 and 24; at the last visit a second laparoscopy was performed. Therapeutic efficacy was evaluated by analysis of the laparoscopic scores assessed according to the revised American Fertility Society classification. Symptomatic response was measured by clinical scores and laboratory data. In one centre, bone mineral density was also recorded. One patient in the danazol group discontinued treatment due to a cutaneous rash as a probable adverse reaction at the beginning of the study. The therapeutic efficacy of danazol and gestrinone did not differ significantly when the revised American Fertility Society scores were compared. The symptomatic response also showed no statistical difference when clinical examination scores were analysed. There was no significant difference between the drugs in laboratory data, including bone mineral density, with respect to adverse events. Analysis of clinical scores showed that danazol was superior to gestrinone with respect to acne and irregular bleeding. Based on these data, we conclude that both danazol and gestrinone are reliable in the treatment of endometriosis and offer similar results.


Asunto(s)
Danazol/uso terapéutico , Endometriosis/tratamiento farmacológico , Antagonistas de Estrógenos/uso terapéutico , Gestrinona/uso terapéutico , Adulto , Danazol/efectos adversos , Antagonistas de Estrógenos/efectos adversos , Femenino , Gestrinona/efectos adversos , Humanos , Resultado del Tratamiento
3.
Fertil Steril ; 57(2): 439-41, 1992 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-1735499

RESUMEN

Oocyte donation is a novel alternative for the treatment of patients who have infertility associated with ovarian failure. Both IVF-ET and GIFT represent new techniques of treatment for this group of patients. Synchronization between donor and recipient is very simple and also flexible. In our study population, four patients received oocyte or embryo donation after at least 20 days of E replacement, and two of them conceived a clinical pregnancy. Apparently, the flexibility of our protocol of E replacement allows an extension of the proliferative phase in cases that need to have additional time to synchronize the recipient's cycle to that of the donors.


Asunto(s)
Oocitos , Técnicas Reproductivas , Donantes de Tejidos , Adulto , Brasil , Femenino , Fertilización In Vitro , Transferencia Intrafalopiana del Gameto , Humanos , Embarazo , Resultado del Embarazo
5.
Med Care ; 20(5): 526-34, 1982 May.
Artículo en Inglés | MEDLINE | ID: mdl-7098591

RESUMEN

All women hospitalized for delivery over a ten-week period at the largest maternity hospital in Campinas in the State of São Paulo, Brazil, were questioned about their interest in and plans for sterilization. Results from a categorical data analysis indicate that among the study variables, cesarean delivery was the necessary condition for postpartum sterilization and was significantly associated with the patient's ability to pay for services. Further, the variability in the proportion of women sterilized postpartum was almost perfectly explained by a linear model with main effects for parity and for the patient's ability to pay for services.


PIP: A study was undertaken at a large maternity hospital in Campinas in the State of Sao Paulo, Brazil in an effort to obtain more information concerning access to sterilization. This hospital was chosen because it serves patients of widely varied socioeconomic status, and, consequently of different abilities to pay for surgery. The study was conducted over the December 1979 through February 1980 period. Interviews were completed with 2194 women after they gave birth and before discharge from the hospital. Analysis proceeds in 3 steps: a description concerning distributions of age, parity (after delivery), monthly family income, type of payment for medical services, and method of delivery among the 927 women who desire no more children; a description of how the population desiring no more children chooses sterilization as the preferred family planning method; and focus on the subset of women preferring sterilization services, making use of methods of estimation and hypothesis testing from cross-classified data. Almost 9 of 10 women who want no more children have heard of sterilization. Indigent patients are least likely (79%) and private patients are most likely (98%) to have heard of sterilization. Women who had cesarean deliveries are more likely to have heard of sterilization (95%) than those giving birth vaginally (86%). Of all women who want no more children and have heard of sterilization, 58% stated that they had planned to be sterilized. Of the 375 women who planned to be sterilized and knew about available services, 40% were not sterilized postpartum. The most frequent reason given was type of delivery (38%). Of the women who had vaginal deliveries, 48% gave this as a reason for failure to be sterilized. Study data show that the method of payment for care substantially influences the eventuality of sterilization. Wealthier women who are private or convenio (all women who pay for their care through a privately financed insurance plan but do not stay in a private room) patients are more likely to be sterilized than are the poor, whose care is financed through government insurance or who are indigent. Results also show that women sterilized postpartum almost always have had cesarean deliveries. Regardless of whether she is sterilized, a cesarean delivery is more likely as the socioeconomic status of the woman rises. A more liberal interpretation of the Medical Ethics Code that would consider women to be at high risk for reasons other than those associated with previous cesarean birth would improve access to postpartum sterilization.


Asunto(s)
Accesibilidad a los Servicios de Salud , Periodo Posparto , Esterilización Reproductiva , Adolescente , Adulto , Brasil , Parto Obstétrico/métodos , Ética Médica , Servicios de Planificación Familiar , Femenino , Conocimientos, Actitudes y Práctica en Salud , Humanos , Embarazo , Factores Socioeconómicos , Esterilización Reproductiva/economía , Esterilización Reproductiva/métodos
9.
Med Hoje ; 4(36): 70-5, 1978 Feb.
Artículo en Portugués | MEDLINE | ID: mdl-12311569

RESUMEN

PIP: In 1970, 41.6% of the Brazilian population was represented by children aged 0-14, and by 21.3% of women in fertile age; the birth rate was 36.9/1000. Without an appropriate national program of family planning, Brazil will have in the year 2000, 218.8 million inhabitants. The need for family planning services in Brazil is evident, even more so since abortion is forbidden, unless for therapeutic reasons. A national family planning program should include a complete range of maternal and child services, and screening for high-risk women; in other words, family planning should be thought of and used as preventive medicine. Family planning is not so much a right as a duty of the couple. The Catholic church, largely prevalent in Brazil, approves of family planning when practiced with the means allowed by the church itself.^ieng


Asunto(s)
Servicios de Planificación Familiar , Servicios de Salud , Centros de Salud Materno-Infantil , Crecimiento Demográfico , Américas , Brasil , Atención a la Salud , Demografía , Países en Desarrollo , Salud , América Latina , Población , Dinámica Poblacional , Atención Primaria de Salud , Investigación , América del Sur , Estadística como Asunto
10.
Femina ; 4(5): 298-300, 1976 May.
Artículo en Portugués | MEDLINE | ID: mdl-12159220

RESUMEN

PIP: In a survey of 993 patients complaining of sterility and infertility, 365 were found to suffer from ovulatory disorders, and 133 of the latter were taking oral contraceptives. The patients were subjected to the following tests: basal temperature (monophasic curve in 33.08% of the cases), cervical mucus (negative crystallization in 40.60%), endometrium biopsy (Proliferative in 45.11%), and vaginal cytology (anovulatory pattern in 16.53% of the cases). Laparoscopy was used in 35 cases and biopsy of the ovaries in 18. After treatment with various drugs (such as cyclophenyl, clomiphene, human menopausal gonadotropin, human chorionic gonadotropin, estrogen, progestogen, corticoids, oral contraceptives), improvements were obtained in 82.93% of the cases with respect to basal temperature (from monophasic to biphasic), in 90.90% for cervical mucus (positive crystallization), in 35.28% for endometrium biopsy (from proliferative to sectretory), and in 42.86% for vaginal cytology (from anovulatory to ovulatory pattern). 45 pregnancies were obtianed. It is conluded that oral contraceptives can inhibit ovulation after suspending treatment, irrespective of its duration, especially in women previously suffering from menstrual disorders. The overall incidence of this syndrome is low, and it is generally reversible. It is desirable, however, to identify the women exposed to high risk of its occurrence, should the patient desire to stop the contraceptive treatment and have more children.^ieng


Asunto(s)
Corticoesteroides , Anovulación , Temperatura Corporal , Moco del Cuello Uterino , Gonadotropina Coriónica , Clomifeno , Anticonceptivos Orales , Recolección de Datos , Endometrio , Estrógenos , Gonadotropinas , Histología , Progesterona , Vagina , Biología , Cuello del Útero , Anticoncepción , Enfermedad , Sistema Endocrino , Servicios de Planificación Familiar , Fármacos para la Fertilidad , Genitales , Genitales Femeninos , Hormonas , Laparoscopía , Trastornos de la Menstruación , Ovario , Fisiología , Progestinas , Sustancias para el Control de la Reproducción , Investigación , Muestreo , Sistema Urogenital , Útero , Vaginitis
12.
Reproduccion ; 1(3): 259-62, 1974.
Artículo en Español | MEDLINE | ID: mdl-4464170

RESUMEN

In 330 cases of male sterility, the authors found in the seminal fluid 270 cases of quantitative alteration, 196 of qualitative alteration, 62 cases with biochemical disturbances and 122 patients with infections. After the specific treatment of these patients, the result was that 50 to 58.2% of them presented response for the quantitative, qualitative and biochemical alterations. In the infections, the index obtained was 85.2%. Among these 330 cases, they were obtained 73 cases of pregnancy (22.1%) with eight cases of abortion(10.9%).


Asunto(s)
Gonadotropina Coriónica/uso terapéutico , Clomifeno/uso terapéutico , Dihidrotestosterona/análogos & derivados , Menotropinas/uso terapéutico , Mesterolona , Oligospermia/tratamiento farmacológico , Testosterona/uso terapéutico , Adulto , Antibacterianos/uso terapéutico , Humanos , Infertilidad Masculina/tratamiento farmacológico , Infertilidad Masculina/etiología , Masculino , Mesterolona/uso terapéutico , Vitaminas/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...